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Background: Based on questionnaire criteria, the sensorimotor disorder restless legs syndrome (RLS) has been
reported to have a higher prevalence in rheumatoid arthritis (RA) patients than in the general population. There
has been some speculation that peripheral arthritic symptoms may allow false positive responses to questionnaire
criteria. This study evaluates whether RA patients meeting RLS questionnaire criteria also have objective evidence
of increased periodic limb movements (PLMs) characteristic of RLS.
Methods: Participants were recruited from RA clinic. Questionnaire data collected at study entry included: pain
scores, rheumatoid arthritis disease activity index, Epworth sleepiness scale, Pittsburgh sleep quality index and
RLS diagnostic criteria. Each participant was provided a PAM-RL actigraphic monitor, which attached to the ankle.
This device was worn for two consecutive nights then returned for data download. Laboratory data including
hemoglobin, iron studies, renal function and C-reactive protein levels were collected.
Results: Of the 57 participants, 23 met RLS diagnostic criteria. Those who met RLS criteria demonstrated higher
mean frequency of nocturnal PLMs (19.63/hour; SD:21.13) than those who did not meet RLS criteria (11.13/hour;
SD:12.10; p = 0.033). There were no significant differences between groups in terms of patient characteristics,
disease activity or duration measures. Patients meeting RLS criteria did have poorer sleep quality measures
(p <0.001).
Conclusions: RA patients who met RLS diagnostic criteria demonstrated higher frequencies of nocturnal PLMs
than RA patients who did not meet criteria for RLS. This finding supports use of the RLS diagnostic criteria in
helping to differentiate between RA arthritic symptoms and RLS.
Keywords: Restless legs syndrome, Sleep, Rheumatoid arthritis, Periodic limb movementsBackground
Restless legs syndrome (RLS), also known as Willis Ekbom
disease, is a sensorimotor disorder reported at an in-
creased prevalence in people with rheumatoid arthritis
(RA). In 1986 Reynolds found 30% of a sample of hospital-
ized RA patients had RLS [1]. Subsequently in 1994, Salih
reported RLS in 25% of RA out-patients [2]. In 2003
the International Restless Legs Syndrome Study Group
(IRLSSG) published diagnostic criteria for RLS [3]. Utiliz-
ing these RLS criteria in a Canadian RA outpatient cohort,* Correspondence: r.gjevre@usask.ca
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article, unless otherwise stated.27.7% of patients were found to meet criteria [4]. RA pa-
tients with RLS have been observed to report poorer sleep
quality, increased pain, depression, and poorer quality of
life scores than those without RLS [5].
The IRLSSG essential diagnostic criteria consist of a
four-component questionnaire. All four criteria must be
present to make a diagnosis of RLS and include the fol-
lowing: 1. An urge to move the legs, usually accompanied
by or caused by uncomfortable and unpleasant sensations
in the legs; 2. The urge to move or unpleasant sensations
begin or worsen during periods of rest or inactivity such
as lying or sitting; 3. The urge to move or unpleasant sen-
sations are partially or totally relieved by movements, such
as walking or stretching, at least as long as the activityentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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are worse in the evening or night than during the day or
only occur in the evening or night [3].
There has been some concern that these essential cri-
teria are vulnerable to inclusion of confounding condi-
tions or ‘mimics’ [6]. Arthritic pain has been suggested as
a possible mimic, which may be experienced by patients
in a manner allowing them to meet RLS criteria on a
questionnaire [6]. Conversely, over 90% of RA patients in
a previous study who met RLS criteria felt they could dif-
ferentiate between these leg symptoms and their arthritic
symptoms [4]. However, it may be possible that the pre-
sumed higher prevalence of RLS in RA does relate to
lower extremity arthritic symptoms being interpreted as
RLS features.
In this study we wished to ascertain whether further
evidence might be found to distinguish between RLS
and ‘mimic’ symptoms in RA patients. As RLS is a sen-
sorimotor disorder, increased periodic limb movements
(PLMs) are a characteristic motor finding [7]. We com-
pare the frequency of PLMs as measured by nocturnal
actigraphy, between RA patients meeting RLS diagnostic
criteria and RA patients not meeting criteria.
Methods
Participants were recruited from RA outpatient clinics. Of
the 109 consecutive RA patients invited to participate, 57
consented and completed the study. The majority of those
declining participation expressed disinclination to wear the
actigraphic monitor overnight. There were small differences
in age (mean age in non-participants was 59.7 years and for
participants was 55.1 years) and gender proportion between
those who did not (10 males in 52 non-participants) and
did (9 males in 57 participants) choose to participate.
Inclusion criteria included: diagnosis of rheumatoid
arthritis by a rheumatologist, ability to provide informed
consent, and age over 18. Exclusion criteria included:
current or recent (within last year) pregnancy and joint
replacement within the previous six months. Patients
with known diagnoses of Parkinson’s disease, other non-
RLS movement disorders, or who utilized dopaminergic
therapies were also excluded. RA clinic patients were
interviewed to determine interest and eligibility. Upon
study entry, an in-person interview to complete the RLS
essential diagnostic criteria was conducted. Participants
who met all four criteria were considered to have RLS.
Participants also completed a questionnaire instrument,
which included the disease specific Rheumatoid arth-
ritis disease activity index (RADAI) [8], a visual analogue
scale (VAS) for pain measurement, the Pittsburgh Sleep
Quality Index (PSQI) [9], and the Epworth Sleepiness
Scale (ESS) [10].
During this study we employed the Physical Activity
Monitor- Restless Legs (PAM-RL) actigraphic monitor[Mini Mitter Company Incorporated, A Respironics In-
corporated Company] designed to document physical
activity associated with movement during sleep. Study
participants each received individual training on use of
the actigraphic device and the sleep diary. Participants
were advised to use the actigraph on one leg for two
consecutive nights and record in the sleep diary when
they retired for the night, arose after sleep and when
during the night they may have gotten out of bed.
The PAM-RL has been validated against polysomnogra-
phy for use in actigraphic measurements [11]. It is battery
powered and contains a three-dimensional piezoelectric
sensor assembly that records physical motion. An up/
down sensor is also incorporated into the monitor allow-
ing identification of activity in the vertical compared to
horizontal position. This small device is attached to the
ankle with a Velcro strap. The acceleration signal pro-
duced by body motion is sampled at a rate of 40 times/
second. Four consecutive samples are then averaged and
the result stored in memory at a rate of ten times per sec-
ond. After the study is completed, the stored data is
downloaded using a SmartCable SP serial cable and ana-
lyzed utilizing specific PAM-RL software. Recordings
taken during the time out of bed overnight were excluded
from the data analysis.
Participants were provided with a laboratory requisition
for study-related testing upon study entry and receipt of
their actigraphic device. Included in the requested studies
were complete blood counts (CBC), creatinine, C-reactive
protein, and iron studies (serum ferritin, iron saturation,
total iron binding capacity, serum iron).
This study was approved by the University of Saskatchewan
Biomedical Research Ethics Board, and the Saskatoon
Health Region operational research office. Each par-
ticipant signed a written consent form.
Statistical analysis
Data was entered and analyzed within SPSS v.19.0. Categor-
ical data was compared between groups using Chi-Square
testing, when the cell size was smaller than five, Fishers
Exact test was utilized. Distribution of continuous data was
compared between groups using Mann Whitney U non-
parametric testing. Calculation of sample size utilizing an
alpha value of 0.05, beta of 0.20, minimal clinical PLM
index difference of 5 and published standard deviation data
[7,11] yielded a sample size requirement estimation of six-
teen participants per group [12].
Results
Of the 57 RA patients who participated in this study, 9
were male (15.8%). The mean age of participants was
55.13 years (SD: 14.9; range 23–87). Of the 57 participants,
23 met the essential diagnostic criteria for restless legs syn-
drome and 34 did not. These two groups of participants







PLMs/hour Night 1 10.62 (12.35) 20.04 (21.76) 0.015
PLMs/hour Night 2 11.59 (13.05) 19.22 (23.40) 0.088
Average PLMs/hour 11.13 (12.10) 19.63 (22.13) 0.033
Duration of sleep
(hours) Night 1
07:47 (01:29) 08:04 (01:12) 0.459
Duration of sleep
(hours) Night 2
07:46 (01:32) 07:44 (00:51) 0.588
Average sleep
duration (hours)
07:47 (01:27) 07:54 (00:56) 0.890
Mean values provided for non-categorical data; RLS: restless legs syndrome;
SD: standard deviation; PLMs: periodic limb movements.
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(BMI), various laboratory parameters, RA disease activity
assessments, and in sleep health (Table 1).
There were no patients in the RLS group who had ele-
vation in serum creatinine (1 in non-RLS group). Two
patients in the non-RLS group had had a previous lower
extremity joint replacement (>6 months earlier). One pa-
tient in each group was concurrently utilizing a CPAP
(continuous positive airway pressure) device for treat-
ment of obstructive sleep apnea (OSA). There was no
significant difference between groups for ESS scores.
Four patients reported previous diagnoses of RLS. Three
of these four met RLS diagnostic criteria on study entry.
Of these four patients, one was receiving iron supple-
ments and one amitriptyline for the RLS symptoms. No
significant differences in parity were observed between
female participants in each group.
There were no significant differences between these
two groups in measurements of laboratory parameters,
which included: complete blood counts, creatinine, C-
reactive protein, and iron studies (serum ferritin, iron
saturation, total iron binding capacity, serum iron).
In terms of assessments related to rheumatoid arth-
ritis, there were no statistically significant differences in
RADAI scores, or VAS scores for pain between groups.
Periodic limb movements/hour and sleep duration for
each group are described in Table 2 and Figure 1. Sig-
nificantly higher mean PLMs were observed in the RA







Age (years) 54.76 (15.90) 55.65 (13.59) 0.809
Gender [Males: Females] 6:28 3:20 0.468
BMI 27.67 (6.15) 31.25 (8.53) 0.094
VAS pain (cm) 3.34 (2.07) 3.87 (2.24) 0.334
RADAI 2.96 (2.00) 3.66 (2.21) 0.197
PSQI 5.97 (3.47) 9.59 (3.11) <0.001
ESS 7.42 (4.70) 7.87 (4.02) 0.682
Hemoglobin [g/L] 132.50 (15.38) 136.33 (10.07) 0.418
Ferritin [μg/L] 109.42 (118.67) 103.21 (111.17) 0.818
Iron [μmol/L] 15.44 (7.75) 16.43 (6.62) 0.568
C-reactive protein [mg/L] 6.09 (6.72) 4.02 (6.17) 0.144
Parity in female
participants
2.37 (2.42) 1.00 (1.22) 0.071
Duration of RA
diagnosis (years)
10.91 (9.38) 14.83 (12.11) 0.225
*Mean values provided for non-categorical data; RLS: restless legs syndrome;
SD:standard deviation; BMI: body mass index (kilograms/metre2); VAS: visual
analogue scale; cm: centimetres; RADAI: rheumatoid arthritis disease activity
index; PSQI: Pittsburgh sleep quality index; ESS: Epworth Sleepiness Scale;
g: grams; L: litre; μg: microgram; μmol: micromole; mg: milligram.Discussion
In this study, RA patients who met RLS criteria, demon-
strated a higher frequency of nocturnal PLMs than those
participants who did not. This finding supports the
premise that RLS symptoms can be distinguished from
arthritic pain by people with RA. Consequently, these
findings are supportive of the previously reported in-
creased prevalence of RLS (25-30%) in RA populations
[1,2,4].
The proportion of participants meeting RLS criteria in
our study is higher than in other questionnaire preva-
lence studies in RA populations. We expect this likely
relates to self-selection bias in patient participation.
Those with symptoms suggestive of RLS may have been
more likely to agree to participate in this study than
those without such symptoms.
The purpose of this study was to compare motor mani-
festations of RLS in RA patients who did and did not meet
RLS criteria. Additionally, this study was not designed or
powered to evaluate authoritatively any pathologic or
physiologic associations with RLS in this patient popula-
tion. The physiologic basis for an increased prevalence of
RLS in RA patients has not been established. There has
been a substantial body of work in other populations iden-
tifying iron deficiency states, parity, renal failure and some
neurologic diseases to be associated with higher risk for
development of RLS [3]. Dopaminergic abnormalities have
been hypothesized and dopamine receptor agonists are
widely employed as therapeutic agents for RLS [3].
Various medications have been recognized to influence
periodic limb movement frequencies in both positive
and negative directions. Small numbers of patients in
this study were utilizing various psychoactive medica-
tions, sedatives, or narcotics. There were no significant
differences in use of these medications between study
patients meeting RLS criteria and those who did not.
In this study no clear relationship was identified be-
tween previously recognized risk associations and RLS.
Figure 1 Periodic limb movements recorded over night 1, night 2 and the averages by patient group. **indicates significant difference
between groups, p < 0.05.
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lection, however it may also reflect under-recognition of
disease processes such as subclinical neurologic involve-
ment. There was an observed trend between higher dis-
ease duration and activity and RLS. This finding, although
not statistically significant may signal a relationship be-
tween cumulative exposure to the inflammatory disease or
therapies and development of RLS.
This study was conducted using the PAM-RL ambula-
tory device to detect periodic leg movements. It has
been recognized that there is variability in sensitivity be-
tween types of actigraphic devices, as well as night-to-
night variability in PLM frequency [13,14]. In order to
consider possible ‘first night effect’ and to accommodate
potential night-to-night variability in PLM counts the
study was conducted over two consecutive nights.
Kobayashi in a recent study of actigraphic evaluation in
Japanese patients suggests a longer duration of consecu-
tive observation may further increase sensitivity for diag-
nosis of PLM disorders [13]. Similarly, Gschliesser has
reported bilateral actigraphy may provide greater overall
result consistency than unilateral studies [14].
A relationship between higher PLM counts or indexes has
been observed with sleep restriction and also sleep apnea
[3]. We observed comparable sleep durations between
groups on study nights although this does not exclude the
possibility of previous sleep restriction prior to studynights. Obstructive sleep apnea (OSA) or sleep disordered
breathing have been reported as increased in RA patients
[5,15]. Epworth Sleepiness Scale (ESS) scores have been
demonstrated to have high predictive capacity for OSA in
RA patients [15]. However, in this study population no




The study population may have been influenced by self-
selection bias in patient participation. Those patients in-
vited to participate who recognized having symptoms
suggestive of RLS may have been more likely to agree to
join in the study than those without such symptoms.
This potential study population bias may affect extrapo-
lation of findings, particularly in reference to RLS preva-
lence, to other patient groups.
Confounding influences
Although care was taken to exclude potential partici-
pants utilizing dopamine agonists or similar therapies
used as treatments for RLS, small numbers of partici-
pants were utilizing various other medications with the
potential to impact PLM assessment by either increasing
or decreasing PLMs. These various medications included
sedatives, narcotics and psychoactive agents. Although,
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cations between study patients meeting RLS criteria and
those who did not, it is possible that use of these or use of
other medications (prescription and non-prescription),
which may not be currently recognized to affect PLM
activity, could have influenced study results in either
direction.
Measurement sensitivity
As previously mentioned, there has been discussion around
the benefits to sensitivity of even longer duration of con-
secutive night measurements than were used in this study.
Bilateral simultaneous actigraphic monitoring has also
been suggested to increase sensitivity relative to unilateral
limb monitoring, which was employed in this study. Vari-
ability in the sensitivity of different types of actigraphic de-
vices has also been recognized [13,14].
Conclusions
In this study RA patients meeting RLS essential criteria
had significantly increased periodic limb movements com-
pared to RA patients who did not meet these questionnaire
criteria. This finding supports consideration of screening
RA patients for RLS and also employing the RLS criteria
questionnaire for the screening process [5,15]. Appropriate
recognition of RLS and potentially subsequent directed
therapies [16,17] may prove beneficial to quality of life in
this patient population.
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